Association Between Corticosteroids and Outcomes in Children Hospitalized With Orbital Cellulitis.


Journal

Hospital pediatrics
ISSN: 2154-1671
Titre abrégé: Hosp Pediatr
Pays: United States
ID NLM: 101585349

Informations de publication

Date de publication:
01 01 2022
Historique:
pubmed: 9 12 2021
medline: 15 3 2022
entrez: 8 12 2021
Statut: ppublish

Résumé

To examine the association between systemic corticosteroid use and outcomes for children hospitalized with orbital cellulitis at US children's hospitals. We conducted a multicenter observational study using administrative data from the Pediatric Health Information System database from 2007 to 2019. Children between the ages of 2 months and 18 years with International Classification of Diseases, Ninth Revision, Clinical Modification or 10th Revision, Clinical Modification discharge diagnostic codes of orbital cellulitis were included. The primary exposure was receipt of systemic corticosteroids on the day of hospital admission. The primary outcome was hospital length of stay, and secondary outcomes included surgical intervention, ICU admissions, revisits, and health care costs. We used generalized logit model with inverse probability weighting logistic regression to adjust for demographic factors and assess for differences in clinical outcomes reported. Of the 5832 patients hospitalized with orbital cellulitis, 330 (5.7%) were in the corticosteroid group and 5502 (94.3%) were in the noncorticosteroid group. Patients in the corticosteroid group were older, had more severe illness, and received broad spectrum antibiotics. In adjusted analyses, corticosteroid exposure was not associated with differences in length of hospital stay, need for surgical intervention, ICU admissions, emergency department revisits, 30-day hospital readmissions, or hospital costs. Restricting the analysis to only those patients who received broad spectrum antibiotics did not change the findings. Early use of systemic corticosteroids in hospitalized children with orbital cellulitis is not associated with improved clinical outcomes. Use of corticosteroids in hospitalized children with orbital cellulitis should be discouraged outside of clinical trials.

Identifiants

pubmed: 34877598
pii: 183796
doi: 10.1542/hpeds.2021-005910
doi:

Substances chimiques

Adrenal Cortex Hormones 0

Types de publication

Journal Article Multicenter Study Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

70-89

Informations de copyright

Copyright © 2021 by the American Academy of Pediatrics.

Déclaration de conflit d'intérêts

FINANCIAL DISCLOSURE: The authors have indicated they have no financial relationships relevant to this article to disclose.

Auteurs

Peter J Gill (PJ)

Division of Paediatric Medicine, Department of Paediatrics, Faculty of Medicine.
Institute of Health Policy, Management and Evaluation.
Hospital for Sick Children, Toronto, Ontario, Canada.
Child Health Evaluative Sciences, SickKids Research Institute, Toronto, Ontario, Canada.

Sanjay Mahant (S)

Division of Paediatric Medicine, Department of Paediatrics, Faculty of Medicine.
Institute of Health Policy, Management and Evaluation.
Hospital for Sick Children, Toronto, Ontario, Canada.
Child Health Evaluative Sciences, SickKids Research Institute, Toronto, Ontario, Canada.

Matt Hall (M)

Children's Hospital Association, Lenexa, Kansas.

Patricia C Parkin (PC)

Division of Paediatric Medicine, Department of Paediatrics, Faculty of Medicine.
Hospital for Sick Children, Toronto, Ontario, Canada.
Child Health Evaluative Sciences, SickKids Research Institute, Toronto, Ontario, Canada.

Samir S Shah (SS)

Division of Hospital Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.

Nikolaus E Wolter (NE)

Department of Otolaryngology, Head & Neck Surgery, The University of Toronto, Toronto, Ontario, Canada.
Hospital for Sick Children, Toronto, Ontario, Canada.

Marcos Mestre (M)

Nicklaus Children's Hospital, Miami, Florida.

Jessica L Markham (JL)

Children's Mercy Kansas City, Kansas City, Missouri.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH